Literature DB >> 17016676

Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.

Tána Ravingerová1, Jana Matejíková, Jan Neckár, Eva Andelová, Frantisek Kolár.   

Abstract

Endogenous cardiac protection against prolonged ischemic insult can be achieved by repeated brief episodes of ischemia (hypoxia) or by cardiac adaptation to various stresses such as chronic hypoxia. Activation of phosphatidylinositol 3-kinase (PI3K)/Akt is involved in antiapoptotic effects, however, it is not clear whether it is required for overall heart salvage including protection against myocardial infarction and arrhythmias. We focussed on the potential common role of PI3K/Akt in anti-infarct protection, in the experimental settings of long-term adaptation to chronic intermittent hypobaric hypoxia (IHH; 8 h/day, 25-30 exposures, in vivo rats) and acute ischemic preconditioning (IP; Langendorff-perfused hearts). In addition, we explored the role of PI3K/Akt in susceptibility to ischemic ventricular arrhythmias. In normoxic open-chest rats, PI3K/Akt inhibitor LY294002 (LY; 0.3 mg/kg) given 5 min before test occlusion/reperfusion (I/R) did not affect infarct size (IS) normalized to the size of area at risk (AR). In hypoxic rats, LY partially attenuated IS-limiting effect of IHH (IS/AR 59.7 +/- 4.1% vs. 51.8 +/- 4.4% in the non-treated rats; p > 0.05) and increased IS/AR to its value in normoxic rats (64.9 +/- 5.1%). In the isolated hearts, LY (5 muM) applied 15 min prior to I/R completely abolished anti-infarct protection by IP (IS/AR 55.0 +/- 4.9% vs. 15.2 +/- 1.2% in the non-treated hearts and 42.0 +/- 5.5% in the non-preconditioned controls; p < 0.05). In the non-preconditioned hearts, PI3K/Akt inhibition did not modify IS/AR, on the other hand, it markedly suppressed arrhythmias. In the LY-treated isolated hearts, the total number of ventricular premature beats and the incidence of ventricular tachycardia (VT) was reduced from 518 +/- 71 and 100% in the controls to 155 +/- 15 and 12.5%, respectively (p < 0.05). Moreover, bracketing of IP with LY did not reverse antiarrhythmic effect of IP. These results suggest that activation of PI3K/Akt cascade plays a role in the IS-limiting mechanism in the rat heart, however, it is not involved in the mechanisms of antiarrhythmic protection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016676     DOI: 10.1007/s11010-006-9335-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  PI3King the L-type calcium channel activation mechanism.

Authors:  S F Steinberg
Journal:  Circ Res       Date:  2001-10-12       Impact factor: 17.367

2.  Normal function of HERG K+ channels expressed in HEK293 cells requires basal protein kinase B activity.

Authors:  Yiqiang Zhang; Huizhen Wang; Jingxiong Wang; Hong Han; Stanley Nattel; Zhiguo Wang
Journal:  FEBS Lett       Date:  2003-01-16       Impact factor: 4.124

3.  IGF-1 up-regulates K+ channels via PI3-kinase, PDK1 and SGK1.

Authors:  N Gamper; S Fillon; S M Huber; Y Feng; T Kobayashi; P Cohen; F Lang
Journal:  Pflugers Arch       Date:  2001-11-14       Impact factor: 3.657

4.  Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt.

Authors:  Suofu Qin; P Boon Chock
Journal:  Biochemistry       Date:  2003-03-18       Impact factor: 3.162

5.  Preconditioning-induced cardioprotection and release of the second messenger inositol (1,4,5)-trisphosphate are both abolished by neomycin in rabbit heart.

Authors:  B Bauer; B Z Simkhovich; R A Kloner; K Przyklenk
Journal:  Basic Res Cardiol       Date:  1999-02       Impact factor: 17.165

6.  Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling.

Authors:  Soochan Bae; Lubo Zhang
Journal:  J Pharmacol Exp Ther       Date:  2005-08-11       Impact factor: 4.030

7.  Myocardial Akt activation and gender: increased nuclear activity in females versus males.

Authors:  D Camper-Kirby; S Welch; A Walker; I Shiraishi; K D Setchell; E Schaefer; J Kajstura; P Anversa; M A Sussman
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

8.  Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium.

Authors:  C Strohm; T Barancik; M L Brühl; S A Kilian; W Schaper
Journal:  J Cardiovasc Pharmacol       Date:  2000-08       Impact factor: 3.105

9.  Increased expression and altered subcellular distribution of PKC-delta in chronically hypoxic rat myocardium: involvement in cardioprotection.

Authors:  Jan Neckár; Irena Marková; Frantisek Novák; Olga Nováková; Ondrej Szárszoi; Bohuslav Ost'ádal; Frantisek Kolár
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-02       Impact factor: 4.733

10.  Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection.

Authors:  Parvaneh Rafiee; Yang Shi; Xiangrong Kong; Kirkwood A Pritchard; James S Tweddell; S Bert Litwin; Kathleen Mussatto; Robert D Jaquiss; Jidong Su; John E Baker
Journal:  Circulation       Date:  2002-07-09       Impact factor: 29.690

View more
  29 in total

1.  The effect of uraemia on the duration of arrhythmias in the context of cardioprotective ischaemic conditioning strategies.

Authors:  Kieran McCafferty; Conor J Byrne; Julius Kieswich; Martin Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Heart Asia       Date:  2014-05-24

2.  DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.

Authors:  Hui-Chun Ku; Wen-Pin Chen; Ming-Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-12       Impact factor: 3.000

Review 3.  Preconditioning and stem cell survival.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Cardiovasc Transl Res       Date:  2009-12-22       Impact factor: 4.132

4.  Proteomic mechanisms of cardioprotection during mammalian hibernation in woodchucks, Marmota monax.

Authors:  Hong Li; Tong Liu; Wei Chen; Mohit Raja Jain; Dorothy E Vatner; Stephen F Vatner; Raymond K Kudej; Lin Yan
Journal:  J Proteome Res       Date:  2013-08-06       Impact factor: 4.466

5.  Testosterone-down-regulated Akt pathway during cardiac ischemia/reperfusion: a mechanism involving BAD, Bcl-2 and FOXO3a.

Authors:  Chunyan Huang; Hongmei Gu; Wenjun Zhang; Jeremy L Herrmann; Meijing Wang
Journal:  J Surg Res       Date:  2010-08-17       Impact factor: 2.192

6.  Up-regulation and redistribution of protein kinase C-δ in chronically hypoxic heart.

Authors:  Markéta Hlaváčková; Kristýna Kožichová; Jan Neckář; František Kolář; René J P Musters; František Novák; Olga Nováková
Journal:  Mol Cell Biochem       Date:  2010-09-19       Impact factor: 3.396

7.  Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.

Authors:  Lalita Babbar; Nanjaian Mahadevan; Pitchai Balakumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-17       Impact factor: 3.000

8.  Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.

Authors:  Meijing Wang; Yue Wang; Brent Weil; Aaron Abarbanell; Jeremy Herrmann; Jiangning Tan; Megan Kelly; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-11       Impact factor: 3.619

9.  Sauchinone augments cardiomyocyte viability by enhancing autophagy proteins -PI3K, ERK(1/2), AMPK and Beclin-1 during early ischemia-reperfusion injury in vitro.

Authors:  Bisharad Anil Thapalia; Zhen Zhou; Xianhe Lin
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

10.  Chronic intermittent hypoxia affects the cytosolic phospholipase A2α/cyclooxygenase 2 pathway via β2-adrenoceptor-mediated ERK/p38 stimulation.

Authors:  Petra Micova; Klara Hahnova; Marketa Hlavackova; Barbara Elsnicova; Anna Chytilova; Kristyna Holzerova; Jitka Zurmanova; Jan Neckar; Frantisek Kolar; Olga Novakova; Jiri Novotny
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.